ann_arbor_pathologic_stage,aligned_reads_files,cause_of_response,wilms_tumor_histologic_subtype,peripancreatic_lymph_nodes_tested,experiment_name
Not Reported,tumor_sample_01.bam,Genetic mutation,Favorable,0,CellProliferation_Assay_HD33
Stage I,normal_sample_01.bam,Immunotherapy response,Not Reported,1,ApoptosisRate_MCF7_Cisplatin
Stage II,patientA_tumor_rep1.bam,Chemotherapy resistance,Unfavorable,2,GeneExpression_T47D_Estrogen
Stage III,patientA_normal_rep1.bam,Radiation therapy effect,Unknown,3,MigrationAssay_PC3_Control
Stage IV,sample02_tumor_aligned_reads.bam,Hormonal therapy outcome,Not Reported,4,InvasionAssay_A549_TGFbeta
Unknown,sample02_normal_aligned_reads.bam,Targeted therapy response,Unfavorable,5,DrugSensitivity_GBM8401_Temozolomide
Stage III,patientB_tumor_replicate2.bam,Surgical intervention impact,Not Reported,6,Angiogenesis_HUVEC_VEGF
Stage I,patientB_normal_replicate2.bam,Spontaneous regression,Unfavorable,7,DNARepair_U2OS_Radiation
Stage IV,primary_tumor_03.bam,Infection-related response,Favorable,8,ProteinStability_SKBR3_Herceptin
Not Reported,metastasis_sample_03.bam,Environmental factor influence,Unknown,9,Metabolomics_HepG2_Sorafenib
Stage III,control_sample_04.bam,Lifestyle-related effect,Unfavorable,10,Immunogenicity_LC540_Carboplatin
Stage IV,carcinoma_sample_05.bam,Metabolic change response,Favorable,12,StemCellFrequency_K562_Nilotinib
Stage I,lymph_node_sample_06.bam,Psychological stress impact,Unknown,14,ChromatinAccessibility_HeLa_DMSO
Stage III,patientC_tumor_rep3.bam,Nutritional factor response,Unfavorable,16,Autophagy_MDA231_Chloroquine
Stage II,patientC_normal_rep3.bam,Microbiome influence,Not Reported,18,Senescence_BJ_Fibroblast_TGFalpha
